These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 16616230

  • 1. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
    Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS, PREVENT III Investigators.
    J Vasc Surg; 2006 Apr; 43(4):742-751; discussion 751. PubMed ID: 16616230
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
    Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT, PREVENT IV Investigators.
    JAMA; 2005 Nov 16; 294(19):2446-54. PubMed ID: 16287955
    [Abstract] [Full Text] [Related]

  • 3. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial.
    Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS.
    J Vasc Surg; 2007 Dec 16; 46(6):1180-90; discussion 1190. PubMed ID: 18154993
    [Abstract] [Full Text] [Related]

  • 4. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.
    Arvela E, Venermo M, Söderström M, Albäck A, Lepäntalo M.
    Ann Vasc Surg; 2012 Apr 16; 26(3):396-403. PubMed ID: 22285375
    [Abstract] [Full Text] [Related]

  • 5. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft.
    Pulli R, Dorigo W, Castelli P, Dorrucci V, Ferilli F, De Blasis G, Monaca V, Vecchiati E, Pratesi C, Propaten Italian Registry Group.
    J Vasc Surg; 2010 May 16; 51(5):1167-1177.e1. PubMed ID: 20347549
    [Abstract] [Full Text] [Related]

  • 6. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130.
    Kreatsoulas C, Anand SS.
    Vasc Med; 2009 Nov 16; 14(4):397-9. PubMed ID: 19808727
    [Abstract] [Full Text] [Related]

  • 7. Infrainguinal vein bypass graft revision: factors affecting long-term outcome.
    Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, Whittemore AD, Belkin M.
    J Vasc Surg; 2004 Nov 16; 40(5):916-23. PubMed ID: 15557905
    [Abstract] [Full Text] [Related]

  • 8. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
    Conte MS, Lorenz TJ, Bandyk DF, Clowes AW, Moneta GL, Seely BL.
    Vasc Endovascular Surg; 2005 Nov 16; 39(1):15-23. PubMed ID: 15696244
    [Abstract] [Full Text] [Related]

  • 9. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
    Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, Conte MS, Vascular Study Group of Northern New England.
    J Vasc Surg; 2009 Oct 16; 50(4):769-75; discussion 775. PubMed ID: 19628361
    [Abstract] [Full Text] [Related]

  • 10. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    Owens CD, Kim JM, Hevelone ND, Hamdan A, Raffetto JD, Creager MA, Conte MS.
    J Vasc Surg; 2010 May 16; 51(5):1152-9. PubMed ID: 20223619
    [Abstract] [Full Text] [Related]

  • 11. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
    Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS.
    J Vasc Surg; 2008 Apr 16; 47(4):774-781. PubMed ID: 18381138
    [Abstract] [Full Text] [Related]

  • 12. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.
    Berceli SA, Hevelone ND, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Conte MS.
    J Vasc Surg; 2007 Dec 16; 46(6):1173-1179. PubMed ID: 17950564
    [Abstract] [Full Text] [Related]

  • 13. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia.
    Arvela E, Söderström M, Albäck A, Aho PS, Venermo M, Lepäntalo M.
    J Vasc Surg; 2010 Sep 16; 52(3):616-23. PubMed ID: 20615645
    [Abstract] [Full Text] [Related]

  • 14. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program.
    Carter A, Murphy MO, Halka AT, Turner NJ, Kirton JP, Murray D, Bodill H, Millar ML, Mason T, Smyth JV, Walker MG.
    Ann Vasc Surg; 2007 Nov 16; 21(6):695-703. PubMed ID: 17980793
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB, Morrissey NJ, Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators.
    J Vasc Surg; 2015 Mar 16; 61(3):703-12.e1. PubMed ID: 25720929
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic vein harvest does not negatively affect patency of great saphenous vein lower extremity bypass.
    Khan SZ, Rivero M, McCraith B, Harris LM, Dryjski ML, Dosluoglu HH.
    J Vasc Surg; 2016 Jun 16; 63(6):1546-54. PubMed ID: 27005753
    [Abstract] [Full Text] [Related]

  • 17. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
    Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L.
    J Vasc Surg; 2005 Sep 16; 42(3):456-64; discussion 464-5. PubMed ID: 16171587
    [Abstract] [Full Text] [Related]

  • 18. Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia.
    Scali ST, Beck AW, Nolan BW, Stone DH, De Martino RR, Chang CK, Rzucidlo EM, Walsh DB.
    J Vasc Surg; 2011 Oct 16; 54(4):1006-10. PubMed ID: 21820833
    [Abstract] [Full Text] [Related]

  • 19. Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts.
    Arvela E, Kauhanen P, Albäck A, Lepäntalo M, Neufang A, Adili F, Schmitz-Rixen T, ProVena Study Group.
    Eur J Vasc Endovasc Surg; 2009 Oct 16; 38(4):456-62. PubMed ID: 19564122
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
    Oresanya L, Makam AN, Belkin M, Moneta GL, Conte MS.
    J Vasc Surg; 2014 Apr 16; 59(4):996-1002. PubMed ID: 24361199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.